Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy-Reference-Cited by-同舟云学术

Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy

Published:2019-12-19 Issue:2 Volume:111 Page:548-560
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Okamura Yukiyasu¹^ORCID,Yasukawa Satoru²,Narimatsu Hiroto³^ORCID,Boku Narikazu⁴,Fukutomi Akira⁵,Konishi Masaru⁶,Morinaga Soichiro⁷,Toyama Hirochika⁸,Kaneoka Yuji⁹,Shimizu Yasuhiro¹⁰,Nakamori Shoji¹¹,Sata Naohiro¹²,Yamakita Keisuke¹³,Takahashi Amane¹⁴,Kainuma Osamu¹⁵,Hishinuma Shoichi¹⁶,Yamaguchi Ryuzo¹⁷,Nagino Masato¹⁸,Hirano Satoshi¹⁹,Yanagisawa Akio²,Mori Keita²⁰,Uesaka Katsuhiko¹

Affiliation:

1. Division of Hepato‐Biliary‐Pancreatic Surgery Shizuoka Cancer Center Hospital Nagaizumi Japan

2. Pathology Kyoto Prefectural University of Medicine Kyoto Japan

3. Cancer Prevention and Control Division Kanagawa Cancer Center Yokohama Japan

4. Gastrointestinal Medical Oncology National Cancer Center Hospital Tokyo Japan

5. Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

6. Hepato‐Biliary‐Pancreatic Surgery National Cancer Center Hospital East Kashiwa Japan

7. Department of Gastrointestinal Surgery Kanagawa Cancer Center Yokohama Japan

8. Hepato‐Biliary‐Pancreatic Surgery Kobe University Kobe Japan

9. Surgery Ogaki Municipal Hospital Ogaki Japan

10. Gastrointestinal Surgery Aichi Cancer Center Hospital Nagoya Japan

11. Surgery National Hospital Organization Osaka National Hospital Osaka Japan

12. Gastrointestinal Surgery Jichi Medical University Shimotsuke Japan

13. Division of Metabolism and Biosystemic Science Department of Medicine Asahikawa Medical University Asahikawa Japan

14. Gastrointestinal Surgery Saitama Cancer Center Saitama Japan

15. Gastrointestinal Surgery Chiba Cancer Center Chiba Japan

16. Surgery Tochigi Cancer Center Utsunomiya Japan

17. Surgery Kasugai Municipal Hospital Kasugai Japan

18. Division of Surgical Oncology Department of Surgery Nagoya University Graduate of School of Medicine Nagoya Japan

19. Gastroenterological Surgery II Faculty of Medicine Hokkaido University Sapporo Japan

20. Clinical Trial Coordination Office Biostatistician Shizuoka Cancer Center Hospital Nagaizumi Japan

Funder

Daiwa Securities Health Foundation

Takeda Science Foundation

Taiho Pharmaceutical

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14258

Reference27 articles.

1. European cancer mortality predictions for the year 2014

2. New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel

3. Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

4. Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

5. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning of Histopathological Images Predicts Recurrences of Resected Pancreatic Ductal Adenocarcinoma With Adjuvant Treatment;Pancreas;2023-12-21

2. The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy;Journal of Hepato-Biliary-Pancreatic Sciences;2022-05-10

3. Concordance of human equilibrative nucleoside transporter‐1 expressions between murine ( 10D7G2 ) and rabbit ( SP120 ) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial;Cancer Reports;2021-07-29

4. Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy;Journal of Nanobiotechnology;2021-06-15

5. Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine;Frontiers in Oncology;2021-05-28